Cerebral microdialysis for detection of bacterial meningitis in aneurysmal subarachnoid hemorrhage patients: a cohort

Florian Schlenk1, Katja Frieler, Alexandra Nagel

  • 1Department of Neurosurgery, Charité - Universitätsmedizin Berlin, Campus Virchow Klinikum, Berlin, Germany. florian.schlenk@charite.de

Abstract

Insights

Microdialysis (MD) can help diagnose bacterial meningitis (BM) in subarachnoid hemorrhage (SAH) patients. A drop in cerebral glucose levels, combined with fever, shows promise for early BM detection when CSF analysis is inconclusive.

Area of Science:

  • Neuroscience
  • Infectious Diseases
  • Medical Technology

Background:

  • Bacterial meningitis (BM) is a serious complication following aneurysmal subarachnoid hemorrhage (SAH).
  • Standard cerebrospinal fluid (CSF) analysis often fails to detect BM due to overlapping symptoms with SAH.
  • Cerebral microdialysis (MD) monitors brain metabolism and may offer diagnostic value in SAH patients.

Purpose of the Study:

  • To investigate the utility of cerebral microdialysis (MD) for diagnosing bacterial meningitis (BM) in patients with subarachnoid hemorrhage (SAH).
  • To compare the diagnostic performance of MD parameters with traditional CSF analysis for BM in SAH.

Main Methods:

  • A retrospective analysis of 167 SAH patients undergoing MD monitoring was conducted.
  • BM diagnosis was confirmed via CSF culture or clinical response to antibiotics with elevated CSF cell count/fever.
  • MD parameters were analyzed before and after BM diagnosis and compared to controls without BM.

Main Results:

  • BM developed in 20 patients; 12 were monitored by MD at diagnosis.
  • A significant decrease in cerebral glucose was observed on the day of BM diagnosis compared to baseline and controls.
  • A decrease in cerebral glucose (1 mmol/L) plus fever (>=38°C) showed 69% sensitivity and 80% specificity for BM.

Conclusions:

  • Cerebral microdialysis (MD) glucose decrease combined with fever can aid in diagnosing BM in SAH patients.
  • CSF chemistry was not indicative of BM, though CSF cell counts increased prior to diagnosis.
  • MD serves as a valuable adjunct for early BM diagnosis in SAH patients, especially when CSF analysis is unhelpful.

Related Concept Videos

Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...